Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Jayamas Medica Industri Tbk
OMED
Sector: Healthcare
Industry: Healthcare Equipment & Supplies
Sub Sector: Healthcare Equipment & Providers
Sub Industry: Healthcare Supplies & Distributions
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
16
ROE
15,51%
ROA
12,86%
Book Value
105
Net Income
219,44 M
Total Sales
1,17 T
Total Assets
3,41 T
DER
0.19x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
4,09%
INTISUMBER HASILSEMPURNA 🔗
83,30%
Corporate · Lokal
EFG BANK AG, SINGAPORE BRANCH A/C CLIENTS 🔗
4,99%
Private Bank · Asing
ASIAN DEVELOPMENT BANK (ADB) 🔗
3,43%
International Organization · Asing
VENTURA INOVASI PERTAMA, PT 🔗
1,67%
Investment Advisors · Lokal
PT PUNCAK SEGAR ABADI 🔗
1,48%
Investment Advisors · Lokal
ANAK GUNUNG SENTOSA PT 🔗
1,04%
Corporate · Lokal
Tentang Perusahaan
PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Produk & Lini Bisnis
The Company is engaged in the business of manufacturing medical devices, electromedical medical devices, diagnostic tools, antiseptics and disinfectants, and other household health supplies. The Company’s main activities currently are manufacturing and distribution of medical devices.
Dewan Direksi
DH
Dra. Herlien Sri Ariani, APT
President Director
LH
Leonard Hariadi Hartanto
Director
LK
Louis Krisnadi Hartanto
Director
ES
Eka Suwignyoo
Director
Dewan Komisaris
YJ
Yacobus Jemmy Hartanto
President Commissioner
DA
David Allen Worth
Independent Commissioner
SS
Siane Soetanto
Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
 %
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
2,1M 1,5M 1,0M 516jt 0 Sales 2025Q2: Rp 925.846.133 Net Income 2025Q2: Rp 153.731.316 2025Q2 Sales 2025Q3: Rp 1.469.894.209 Net Income 2025Q3: Rp 254.208.487 2025Q3 Sales 2025Q4: Rp 2.063.816.901 Net Income 2025Q4: Rp 366.948.756 2025Q4 Sales 2026Q1: Rp 572.248.286 Net Income 2026Q1: Rp 98.369.588 2026Q1 Sales 2026Q2: Rp 1.166.793.477 Net Income 2026Q2: Rp 219.440.694 2026Q2
2025 Q2
EPS 11
ROE 12,22%
2025 Q3
EPS 13
ROE 12,97%
2025 Q4
EPS 14
ROE 13,49%
2026 Q1
EPS 15
ROE 13,96%
2026 Q2
EPS 16
ROE 15,51%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 1,17 T 219,44 M 3,41 T 2,83 T 16 15,51% 0.19x
2026 Q1 572,25 M 98,37 M 3,32 T 2,82 T 15 13,96% 0.17x
2025 Q4 2,06 T 366,95 M 3,20 T 2,72 T 14 13,49% 0.16x
2025 Q3 1,47 T 254,21 M 3,03 T 2,61 T 13 12,97% 0.15x
2025 Q2 925,85 M 153,73 M 2,84 T 2,52 T 11 12,22% 0.11x
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 206 105 12,86%
2026 1 258 104 11,85%
2025 4 206 101 11,47%
2025 3 200 97 11,17%
2025 2 176 93 10,84%
Data diperbarui pada: 2026-05-12 11:30:36